Last updated on April 2019

Study to Assess the Safety Tolerability Efficacy and PK of APL-2 in Patients With wAIHA or CAD


Brief description of study

This study is to assess the safety, tolerability, preliminary efficacy, and pharmacokinetics of APL-2 in subjects with warm Autoimmune Hemolytic Anemia (wAIHA) or Cold Agglutinin Disease (CAD).

Clinical Study Identifier: NCT03226678

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.